指南与共识肺结节与肺癌

Chest指南执行摘要:肺癌低剂量CT筛查

Executive Summary: Screening for Lung Cancer: Chest Guideline and Expert Panel Report.
指南 / 共识 · Chest · 2021-07-13

Chest指南专家小组基于系统综述新增75项研究,更新肺癌低剂量CT筛查获益、危害与实施的证据,形成7条分级推荐和9条未分级共识声明,认为筛查可取得获益与危害的有利平衡。

要点

  • 低剂量CT筛查肺癌可取得获益与危害的有利平衡。
  • 筛查对象选择、影像质量与判读、筛查发现管理及戒烟干预效果可影响该平衡。
  • 指南给出7条分级推荐和9条未分级共识声明指导筛查实施。

核心结论

  • 证据提示肺癌低剂量CT筛查可获得获益与危害的有利平衡,且多项实施因素可影响该平衡。

研究设计与样本

  • 专家小组以PICO格式审查既有关键问题,自上一版指南发布后每季度系统检索MEDLINE via PubMed、Embase和Cochrane Library,并补充参考文献。
  • 采用GRADE方法评估证据质量,酌情进行Meta分析,经投票修订达成共识,最终形成7条分级推荐和9条未分级共识声明。

主要发现

  • 系统文献综述识别出75项新增研究,用于回答12个关键问题并补充其他临床问题。

关键数值与推荐

  • 形成7条分级推荐和9条未分级共识声明,涉及筛查获益、危害与项目实施关键领域。

临床怎么用

  • 临床应关注筛查对象选择、影像质量与判读、筛查发现管理及戒烟干预效果,以优化获益与危害平衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Low-dose chest CT screening for lung cancer has become a standard of care in the United States, in large part because of the results of the National Lung Screening Trial (NLST). Additional evidence supporting the net benefit of low-dose chest CT screening for lung cancer, and increased experience in minimizing the potential harms, has accumulated since the prior iteration of these guidelines. Here, we update the evidence base for the benefit, harms, and implementation of low-dose chest CT screening. We use the updated evidence base to provide recommendations where the evidence allows, and statements based on experience and expert consensus where it does not. METHODS: Approved panelists reviewed previously developed key questions using the Population, Intervention, Comparator, Outcome format to address the benefit and harms of low-dose CT screening, and key areas of program implementation. A systematic literature review was conducted using MEDLINE via PubMed, Embase, and the Cochrane Library on a quarterly basis since the time of the previous guideline publication. Reference lists from relevant retrievals were searched, and additional papers were added. Retrieved references were reviewed for relevance by two panel members. The quality of the evidence was assessed for each critical or important outcome of interest using the Grading of Recommendations, Assessment, Development and Evaluation approach. Meta-analyses were performed where appropriate. Important clinical questions were addressed based on the evidence developed from the systematic literature review. Graded recommendations and ungraded statements were drafted, voted on, and revised until consensus was reached. RESULTS: The systematic literature review identified 75 additional studies that informed the response to the 12 key questions that were developed. Additional clinical questions were addressed resulting in seven graded recommendations and nine ungraded consensus statements. CONCLUSIONS: Evidence suggests that low-dose CT screening for lung cancer can result in a favorable balance of benefit and harms. The selection of screen-eligible individuals, the quality of imaging and image interpretation, the management of screen-detected findings, and the effectiveness of smoking cessation interventions can impact this balance.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Mazzone PJ, Silvestri GA, Souter LH, et al. Executive Summary: Screening for Lung Cancer: Chest Guideline and Expert Panel Report. Chest. 2021. PMID: 34270965. doi:10.1016/j.chest.2021.07.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。